To date, there has been little investigation into the up- and downstream mechanisms controlling EFEMP2 and STEAP2 expression; however, this work suggests that these mechanisms may have a significant impact on the treatment of osteosarcoma. Here, STEAP2 is linked to osteosarcoma.